Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Director's Dealing 2021

Aug 16, 2021

3662_dirs_2021-08-16_6722f14d-8e88-478c-a887-ff843fb597e0.html

Director's Dealing

Open in viewer

Opens in your device viewer

Notification of trade primary insider

Notification of trade primary insider

CEO in Medistim ASA, Kari Krogstad, has sold 40.000 shares in Medstim ASA the

16th of August. The average price per share sold was NOK 339.00. After the sale

Kari Krogstad has 51.802 Medistim shares.